LUNAX vs. SHPAX
Compare and contrast key facts about Saratoga Conservative Balanced Allocation Portfolio (LUNAX) and Saratoga Health & Biotechnology Fund (SHPAX).
LUNAX is managed by Saratoga. It was launched on Dec 28, 2017. SHPAX is managed by Saratoga. It was launched on Jul 14, 1999.
Performance
LUNAX vs. SHPAX - Performance Comparison
Loading graphics...
LUNAX vs. SHPAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
LUNAX Saratoga Conservative Balanced Allocation Portfolio | -2.05% | 10.95% | 8.76% | 9.89% | -8.78% | 10.51% | 7.46% | 14.09% | -5.55% |
SHPAX Saratoga Health & Biotechnology Fund | -1.13% | 17.43% | 0.26% | -0.36% | 1.93% | 16.71% | 3.52% | 27.67% | -9.89% |
Returns By Period
In the year-to-date period, LUNAX achieves a -2.05% return, which is significantly lower than SHPAX's -1.13% return.
LUNAX
- 1D
- 1.57%
- 1M
- -3.51%
- YTD
- -2.05%
- 6M
- -0.72%
- 1Y
- 9.18%
- 3Y*
- 8.27%
- 5Y*
- 4.63%
- 10Y*
- —
SHPAX
- 1D
- 0.96%
- 1M
- -6.78%
- YTD
- -1.13%
- 6M
- 7.84%
- 1Y
- 13.22%
- 3Y*
- 6.93%
- 5Y*
- 5.73%
- 10Y*
- 6.84%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
LUNAX vs. SHPAX - Expense Ratio Comparison
LUNAX has a 0.99% expense ratio, which is lower than SHPAX's 2.90% expense ratio.
Return for Risk
LUNAX vs. SHPAX — Risk / Return Rank
LUNAX
SHPAX
LUNAX vs. SHPAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Saratoga Conservative Balanced Allocation Portfolio (LUNAX) and Saratoga Health & Biotechnology Fund (SHPAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LUNAX | SHPAX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.21 | 0.78 | +0.44 |
Sortino ratioReturn per unit of downside risk | 1.79 | 1.18 | +0.62 |
Omega ratioGain probability vs. loss probability | 1.24 | 1.15 | +0.09 |
Calmar ratioReturn relative to maximum drawdown | 1.70 | 1.56 | +0.14 |
Martin ratioReturn relative to average drawdown | 6.86 | 4.30 | +2.56 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| LUNAX | SHPAX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.21 | 0.78 | +0.44 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.63 | 0.41 | +0.22 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.41 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.59 | 0.30 | +0.30 |
Correlation
The correlation between LUNAX and SHPAX is 0.64, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
LUNAX vs. SHPAX - Dividend Comparison
LUNAX's dividend yield for the trailing twelve months is around 9.56%, more than SHPAX's 3.70% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LUNAX Saratoga Conservative Balanced Allocation Portfolio | 9.56% | 9.36% | 3.54% | 2.54% | 4.91% | 7.81% | 0.46% | 3.57% | 2.14% | 0.00% | 0.00% | 0.00% |
SHPAX Saratoga Health & Biotechnology Fund | 3.70% | 3.66% | 1.35% | 5.38% | 6.34% | 3.76% | 13.82% | 13.24% | 22.00% | 17.98% | 12.52% | 10.70% |
Drawdowns
LUNAX vs. SHPAX - Drawdown Comparison
The maximum LUNAX drawdown since its inception was -18.47%, smaller than the maximum SHPAX drawdown of -69.50%. Use the drawdown chart below to compare losses from any high point for LUNAX and SHPAX.
Loading graphics...
Drawdown Indicators
| LUNAX | SHPAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -18.47% | -69.50% | +51.03% |
Max Drawdown (1Y)Largest decline over 1 year | -5.41% | -7.87% | +2.46% |
Max Drawdown (5Y)Largest decline over 5 years | -11.78% | -16.32% | +4.54% |
Max Drawdown (10Y)Largest decline over 10 years | — | -28.05% | — |
Current DrawdownCurrent decline from peak | -3.93% | -6.99% | +3.06% |
Average DrawdownAverage peak-to-trough decline | -2.89% | -28.07% | +25.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.34% | 2.86% | -1.52% |
Volatility
LUNAX vs. SHPAX - Volatility Comparison
The current volatility for Saratoga Conservative Balanced Allocation Portfolio (LUNAX) is 3.21%, while Saratoga Health & Biotechnology Fund (SHPAX) has a volatility of 4.62%. This indicates that LUNAX experiences smaller price fluctuations and is considered to be less risky than SHPAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| LUNAX | SHPAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.21% | 4.62% | -1.41% |
Volatility (6M)Calculated over the trailing 6-month period | 5.07% | 9.76% | -4.69% |
Volatility (1Y)Calculated over the trailing 1-year period | 7.95% | 16.57% | -8.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 7.44% | 14.19% | -6.75% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 8.77% | 16.57% | -7.80% |